Abstract
Background
Lateral lymph node metastasis (LLNM) occurs in a few of papillary thyroid microcarcinoma (PTMC) cases by the time of diagnosis. Total thyroidectomy (TT) is recommended in the 2015 American Thyroid Association guidelines as the initial surgical procedure for thyroid carcinoma patients with clinically apparent cervical lymph node metastasis. However, none of the controlled studies have focused on the proper extent of surgery for patients who have PTMC with concomitant LLNM without gross extrathyroidal extension (ETE).
Methods
A total of 2373 consecutive patients with PTMC were retrospectively reviewed. Finally, 129 unilateral PTMC patients with ipsilateral LLNM without gross ETE were enrolled in this study and classified into two groups: those who underwent unilateral lobectomy (LT) plus lymph node dissection (LND) (Group I) and those who underwent TT plus LND (Group II). Surgical outcomes and recurrence-free survival (RFS) during the follow-up period were compared between the two groups.
Results
There were 62 patients in Group I and 67 patients in Group II. Cases in Group II had a longer median operation time (150 min vs. 120 min, p < 0.001) and a higher incidence of postoperative hypoparathyroidism (p < 0.001), especially permanent hypoparathyroidism, than cases in Group I. But the RFS showed no statistically significant difference (p = 0.6005) between the two groups during a median follow-up period of 60 months.
Conclusion
Thyroid LT alone plus ipsilateral LND may be an optimum initial procedure for unilateral PTMC patients with ipsilateral LLNM without gross ETE. A long-term follow-up, prospective, randomized controlled trial is warranted.
Similar content being viewed by others
References
Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30
Chen W, Sun K, Zheng R et al (2018) Cancer incidence and mortality in China, 2014. Chin J Cancer Res 30:1–12
Lim H, Devesa SS, Sosa JA et al (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA 317:1338–1348
Mehanna H, Al-Maqbili T, Carter B et al (2014) Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21329 person-years of follow-up. J Clin Endocrinol Metab 99:2834–2843
Yu XM, Wan Y, Sippel RS et al (2011) Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Ann Surg 254:653–660
Turk AT, Asa SL, Baloch ZW et al (2019) Interobserver variability in the histopathologic assessment of extrathyroidal extension of well differentiated thyroid carcinoma supports the New American Joint Committee on Cancer Eighth Edition Criteria for Tumor Staging. Thyroid 29:619–624
Song E, Lee YM, Oh HS et al (2019) A relook at the T stage of differentiated thyroid carcinoma with a focus on gross extrathyroidal extension. Thyroid 29:202–208
Diker-Cohen T, Hirsch D, Shimon I et al (2018) Impact of minimal extra-thyroid extension in differentiated thyroid cancer: systematic review and meta-analysis. J Clin Endocrinol Metab 103(6):2100–2106
Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients With Thyroid Nodules And Differentiated Thyroid Cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26:1–133
Siddiqui S, White MG, Antic T et al (2016) Clinical and pathologic predictors of lymph node metastasis and recurrence in papillary thyroid microcarcinoma. Thyroid 26:807–815
Kim SK, Park I, Woo JW et al (2016) Predictive factors for lymph node metastasis in papillary thyroid microcarcinoma. Ann Surg Oncol 23:2866–2873
So YK, Kim MJ, Kim S et al (2018) Lateral lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis for prevalence, risk factors, and location. Int J Surg 50:94–103
Leboulleux S, Tuttle RM, Pacini F et al (2016) Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? Lancet Diabetes Endocrinol 4:933–942
Miyauchi A, Ito Y, Oda H (2018) Insights into the management of papillary microcarcinoma of the thyroid. Thyroid 28:23–31
Kim SK, Park I, Woo JW et al (2017) Total thyroidectomy versus lobectomy in conventional papillary thyroid microcarcinoma: analysis of 8,676 patients at a single institution. Surgery 161:485–492
Kwon H, Jeon MJ, Kim WG et al (2017) A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study. Eur J Endocrinol 176:371–378
Liu J, Zhang Z, Huang H et al (2019) Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: a single-institution matched-pair analysis. Oral Oncol 90:17–22
Gao M, Ge M, Ji Q et al (2017) 2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma. Cancer Biol Med 14:203–211
Back K, Kim JS, Kim JH et al (2019) Superior located papillary thyroid microcarcinoma is a risk factor for lateral lymph node metastasis. Ann Surg Oncol 26:3992–4001
Haddad RI, Nasr C, Bischoff L et al (2018) NCCN guidelines insights: thyroid carcinoma, version 2.2018. J Natl Compr Cancer Netw 16:1429–1440
Villarroya-Marquina I, Sancho J, Lorente-Poch L et al (2018) Time to parathyroid function recovery in patients with protracted hypoparathyroidism after total thyroidectomy. Eur J Endocrinol 178:103–111
Jeon YW, Gwak HG, Lim ST et al (2019) Long-term prognosis of unilateral and multifocal papillary thyroid microcarcinoma after unilateral lobectomy versus total thyroidectomy. Ann Surg Oncol 26:2952–2958
Song E, Han M, Oh HS et al (2019) Lobectomy is feasible for 1–4 cm papillary thyroid carcinomas: a 10-year propensity score matched-pair analysis on recurrence. Thyroid 29:64–70
Bergenfelz A, Nordenström E, Almquist M (2020) Morbidity in patients with permanent hypoparathyroidism after total thyroidectomy. Surgery 167:124–128
Annebäck M, Hedberg J, Almquist M et al (2020) Risk of permanent hypoparathyroidism after total thyroidectomy for benign disease: a nationwide population-based cohort study from Sweden. Ann Surg. https://doi.org/10.1097/SLA.0000000000003800
Meltzer C, Hull M, Sundang A et al (2019) Association between annual surgeon total thyroidectomy volume and transient and permanent complications. JAMA Otolaryngol Head Neck Surg 145(9):830–837
Zheng W, Li J, Lv P et al (2018) Treatment efficacy between total thyroidectomy and lobectomy for patients with papillary thyroid microcarcinoma: a systemic review and meta-analysis. Eur J Surg Oncol 44:1679–1684
Geron Y, Benbassat C, Shteinshneider M et al (2019) Long-term outcome after hemithyroidectomy for papillary thyroid cancer: a comparative study and review of the literature. Cancers 11(1):26
Kim HJ, Kim NK, Choi JH et al (2013) Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma. Clin Endocrinol (Oxf) 78:614–620
Kim SK, Woo JW, Lee JH et al (2016) Radioactive iodine ablation may not decrease the risk of recurrence in intermediate-risk papillary thyroid carcinoma. Endocr Relat Cancer 23:367–376
Kwon H, Jeon MJ, Kim WG et al (2017) Lack of efficacy of radioiodine remnant ablation for papillary thyroid microcarcinoma: verification using inverse probability of treatment weighting. Ann Surg Oncol 24:2596–2602
Park S, Jeon MJ, Oh HS et al (2018) Changes in serum thyroglobulin levels after lobectomy in patients with low-risk papillary thyroid cancer. Thyroid 28:997–1003
Zern NK, Clifton-Bligh R, Gill AJ et al (2017) Disease progression in papillary thyroid cancer with biochemical incomplete response to initial therapy. Ann Surg Oncol 24:2611–2616
Xu B, Ghossein R (2019) Critical prognostic parameters in the anatomic pathology reporting of differentiated follicular cell-derived thyroid carcinoma. Cancers 11(8):1100
Acknowledgements
We thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Ethical standard
This retrospective study was approved by the Ethics Committee at the Shanghai Jiao Tong University Affiliated Sixth People’s Hospital. Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Song, J., Qiu, W., Yan, T. et al. Comparison of Lobectomy and Total Thyroidectomy in Unilateral Papillary Thyroid Microcarcinoma Patients with Ipsilateral Lateral Lymph Node Metastasis Without Gross Extrathyroidal Extension. World J Surg 44, 2677–2684 (2020). https://doi.org/10.1007/s00268-020-05514-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-020-05514-1